Explosion of Publications, Clinical Trials Driving Growth of Biomarkers Technology

WELLESLEY, Mass., March 5, 2021 (Newswire.com) - Our bodies give us all the clues we need—the trick is reading them correctly.

Biomarkers can be thought of as biological indicators of health and disease. They can be detected visually—with or without imaging—or with a test. 

The global biomarkers market is growing at a significant pace, thanks to new applications of biomarkers as essential tools in drug discovery and development, according to the BCC Research report, Biomarkers: Technologies and Global Markets. 

Enhancements in existing analytical methods and developments of new, sophisticated and sensitive multiplex methods in gene expression analysis, proteomics, metabolomics and transcriptomics are driving this market.  

Development of multi-biomarker assays and novel immunoassays, as well as multi-modal imaging and mass spectrometry methods, are further driving market growth.

Report Highlights

• The global market of biomarker technologies is projected reach $92.1 billion in 2025, up from $43.3 billion in 2020 and rising at a CAGR of 16.3%. 
• Genomics is the fastest growing biomarker technology, expected to rise at a CAGR of 16.8% through 2025. 
• Analysis of key market players: Abbott Laboratories, Johnson & Johnson and Novartis. 

Explore the full report here: https://www.bccresearch.com/market-research/biotechnology/biomarkers-markets-report.html?ur=BIO061F  

About BCC Research 
BCC Research publishes market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering current and emerging industrial and technology sectors. For more information about BCC Research, visit bccresearch.com.

Source: BCC Research